TRANSFORM CVRiD

TRANSFORM CVRiD is a quality improvement effort that evaluates strategies to improve use of guideline-directed therapeutics known to lower cardiovascular (CV) events among patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD). The strategies evaluated include: technology-based decision support, referral to a cardiometabolic team-based care model and general educational tools and resources for clinicians and patients.

Key goals of the study:

  • Quantify initiation of glucagon like peptide-1 receptor agonists (GLP-1RAs) and/or sodium-glucose cotransporter 2 inhibitors (SGLT2i)
  • Understand the effectiveness of various implementation strategies in achieving optimal guideline consistent care

Please review the resources below.

Resources